These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 32422139)
1. Ginsenoside Rh4 suppresses aerobic glycolysis and the expression of PD-L1 via targeting AKT in esophageal cancer. Deng X; Zhao J; Qu L; Duan Z; Fu R; Zhu C; Fan D Biochem Pharmacol; 2020 Aug; 178():114038. PubMed ID: 32422139 [TBL] [Abstract][Full Text] [Related]
2. The ginsenoside Rk3 exerts anti-esophageal cancer activity in vitro and in vivo by mediating apoptosis and autophagy through regulation of the PI3K/Akt/mTOR pathway. Liu H; Zhao J; Fu R; Zhu C; Fan D PLoS One; 2019; 14(5):e0216759. PubMed ID: 31091245 [TBL] [Abstract][Full Text] [Related]
3. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction. Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823 [TBL] [Abstract][Full Text] [Related]
4. β-elemene suppresses the malignant behavior of esophageal cancer cells by regulating the phosphorylation of AKT. Liang Y; Li S; Zheng G; Zhang L Acta Histochem; 2020 May; 122(4):151538. PubMed ID: 32183989 [TBL] [Abstract][Full Text] [Related]
5. Resveratrol inhibits the proliferation and induces the apoptosis in ovarian cancer cells via inhibiting glycolysis and targeting AMPK/mTOR signaling pathway. Liu Y; Tong L; Luo Y; Li X; Chen G; Wang Y J Cell Biochem; 2018 Jul; 119(7):6162-6172. PubMed ID: 29663499 [TBL] [Abstract][Full Text] [Related]
6. Oridonin-induced mitochondria-dependent apoptosis in esophageal cancer cells by inhibiting PI3K/AKT/mTOR and Ras/Raf pathways. Jiang JH; Pi J; Jin H; Cai JY J Cell Biochem; 2019 Mar; 120(3):3736-3746. PubMed ID: 30229997 [TBL] [Abstract][Full Text] [Related]
7. The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121. Peng Y; Zhou Y; Cheng L; Hu D; Zhou X; Wang Z; Xie C; Zhou F Biochem Biophys Res Commun; 2015 Sep; 465(1):137-44. PubMed ID: 26235881 [TBL] [Abstract][Full Text] [Related]
8. Licochalcone A suppresses hexokinase 2-mediated tumor glycolysis in gastric cancer via downregulation of the Akt signaling pathway. Wu J; Zhang X; Wang Y; Sun Q; Chen M; Liu S; Zou X Oncol Rep; 2018 Mar; 39(3):1181-1190. PubMed ID: 29286170 [TBL] [Abstract][Full Text] [Related]
9. The anti-tumor effect of ginsenoside Rh4 in MCF-7 breast cancer cells in vitro and in vivo. Duan Z; Wei B; Deng J; Mi Y; Dong Y; Zhu C; Fu R; Qu L; Fan D Biochem Biophys Res Commun; 2018 May; 499(3):482-487. PubMed ID: 29596831 [TBL] [Abstract][Full Text] [Related]
10. Betulinic acid suppresses breast cancer aerobic glycolysis via caveolin-1/NF-κB/c-Myc pathway. Jiao L; Wang S; Zheng Y; Wang N; Yang B; Wang D; Yang D; Mei W; Zhao Z; Wang Z Biochem Pharmacol; 2019 Mar; 161():149-162. PubMed ID: 30684465 [TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rh4 induces apoptosis and autophagic cell death through activation of the ROS/JNK/p53 pathway in colorectal cancer cells. Wu Q; Deng J; Fan D; Duan Z; Zhu C; Fu R; Wang S Biochem Pharmacol; 2018 Feb; 148():64-74. PubMed ID: 29225132 [TBL] [Abstract][Full Text] [Related]
12. Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway. Chen J; Duan Z; Liu Y; Fu R; Zhu C Nutrients; 2022 Jul; 14(15):. PubMed ID: 35893895 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway. Zhang W; Bhagwath AS; Ramzan Z; Williams TA; Subramaniyan I; Edpuganti V; Kallem RR; Dunbar KB; Ding P; Gong K; Geurkink SA; Beg MS; Kim J; Zhang Q; Habib AA; Choi SH; Lapsiwala R; Bhagwath G; Dowell JE; Melton SD; Jie C; Putnam WC; Pham TH; Wang DH Mol Cancer Ther; 2021 Oct; 20(10):1904-1915. PubMed ID: 34376577 [TBL] [Abstract][Full Text] [Related]
14. The canonical TGF-β/Smad signalling pathway is involved in PD-L1-induced primary resistance to EGFR-TKIs in EGFR-mutant non-small-cell lung cancer. Zhang Y; Zeng Y; Liu T; Du W; Zhu J; Liu Z; Huang JA Respir Res; 2019 Jul; 20(1):164. PubMed ID: 31331328 [TBL] [Abstract][Full Text] [Related]
15. Ginsenoside Rh4 inhibits breast cancer growth through targeting histone deacetylase 2 to regulate immune microenvironment and apoptosis. Dong F; Qu L; Duan Z; He Y; Ma X; Fan D Bioorg Chem; 2023 Jun; 135():106537. PubMed ID: 37043883 [TBL] [Abstract][Full Text] [Related]
16. Ginsenoside Rg3 enhances the anti-proliferative activity of erlotinib in pancreatic cancer cell lines by downregulation of EGFR/PI3K/Akt signaling pathway. Jiang J; Yuan Z; Sun Y; Bu Y; Li W; Fei Z Biomed Pharmacother; 2017 Dec; 96():619-625. PubMed ID: 29035827 [TBL] [Abstract][Full Text] [Related]
17. 2-Deoxy-Rh2: A novel ginsenoside derivative, as dual-targeting anti-cancer agent via regulating apoptosis and glycolysis. Gao H; Liang D; Li C; Xu G; Jiang M; Li H; Yin J; Song Y Biomed Pharmacother; 2020 Apr; 124():109891. PubMed ID: 31991384 [TBL] [Abstract][Full Text] [Related]
18. RAC1 inhibition reverses cisplatin resistance in esophageal squamous cell carcinoma and induces downregulation of glycolytic enzymes. Zeng RJ; Zheng CW; Gu JE; Zhang HX; Xie L; Xu LY; Li EM Mol Oncol; 2019 Sep; 13(9):2010-2030. PubMed ID: 31314174 [TBL] [Abstract][Full Text] [Related]
19. Ginsenoside Rh4 alleviates gastrointestinal mucositis and enhances chemotherapy efficacy through modulating gut microbiota. Bai X; Deng J; Duan Z; Fu R; Zhu C; Fan D Phytomedicine; 2024 Jun; 128():155577. PubMed ID: 38608488 [TBL] [Abstract][Full Text] [Related]
20. Enhanced response to PD-L1 silencing by modulation of TME via balancing glucose metabolism and robust co-delivery of siRNA/Resveratrol with dual-responsive polyplexes. Jia L; Gao Y; Zhou T; Zhao XL; Hu HY; Chen DW; Qiao MX Biomaterials; 2021 Apr; 271():120711. PubMed ID: 33592352 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]